日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Molecular and clinical effects of aromatase inhibitor therapy on skeletal muscle function in early-stage breast cancer

芳香化酶抑制剂治疗对早期乳腺癌骨骼肌功能的分子和临床影响

Tara A Seibert, Lei Shi, Sandra Althouse, Richard Hoffman, Bryan P Schneider, Kristen A Russ, Cody A Altherr, Stuart J Warden, Theresa A Guise, Andrew R Coggan, Tarah J Ballinger

ADAM8 is expressed widely in breast cancer and predicts poor outcome in hormone receptor positive, HER-2 negative patients

ADAM8 在乳腺癌中广泛表达,可预测激素受体阳性、HER-2 阴性患者的预后不良

Stefania Pianetti, Kathy D Miller, Hannah H Chen, Sandra Althouse, Sha Cao, Steven J Michael, Gail E Sonenshein, Nora D Mineva

A phase II study of buparlisib in relapsed or refractory thymomas

布帕利西布治疗复发或难治性胸腺瘤的 II 期研究

Mohammad I Abu Zaid, Milan Radovich, Sandra Althouse, Hao Liu, Aaron J Spittler, Jeffrey Solzak, Sunil Badve, Patrick J Loehrer Sr

Aberrant epigenetic and transcriptional events associated with breast cancer risk

异常表观遗传和转录事件与乳腺癌风险相关

Natascia Marino, Rana German, Ram Podicheti, Douglas B Rusch, Pam Rockey, Jie Huang, George E Sandusky, Constance J Temm, Sandra Althouse, Kenneth P Nephew, Harikrishna Nakshatri, Jun Liu, Ashley Vode, Sha Cao, Anna Maria V Storniolo

Glutamine Metabolism Drives Growth in Advanced Hormone Receptor Positive Breast Cancer

谷氨酰胺代谢促进晚期激素受体阳性乳腺癌的生长

Diane M Demas, Susan Demo, Yassi Fallah, Robert Clarke, Kenneth P Nephew, Sandra Althouse, George Sandusky, Wei He, Ayesha N Shajahan-Haq

Dependence receptor UNC5A restricts luminal to basal breast cancer plasticity and metastasis

依赖性受体 UNC5A 限制管腔至基底乳腺癌的可塑性和转移

Maria B Padua, Poornima Bhat-Nakshatri, Manjushree Anjanappa, Mayuri S Prasad, Yangyang Hao, Xi Rao, Sheng Liu, Jun Wan, Yunlong Liu, Kyle McElyea, Max Jacobsen, George Sandusky, Sandra Althouse, Susan Perkins, Harikrishna Nakshatri